Help Us Fund Research for a Cure for NMO

ALL DONATIONS TO GO TO NMO RESEARCH

Our Story

Hello, we are Matthew and Mahsa, proud parents of our beautiful eight-year-old daughter, Eliyana. Recently, our world was turned upside down when Eliyana was diagnosed with Neuromyelitis Optica (NMO), a rare and devastating neurological disorder. Despite the challenges she faces including current loss of function to her legs, she dives into each day with incredible bravery and a bright spirit that inspires everyone around her.

What is NMO?

NMO is an autoimmune disease that affects the central nervous system, particularly the optic nerves and spinal cord. It can lead to sudden vision loss, paralysis, and other severe neurological symptoms. While there are treatments available to manage the symptoms, there is currently no cure for NMO.

Our Mission

We are determined to change that. Our goal is to raise funds to support cutting-edge research aimed at finding a cure for NMO. In the last 5 years, so much has changed in the world of people suffering NMO and we are confident in the next 5 years a cure will be found. With your help, we can advance scientific understanding and develop new therapies that will not only benefit Eliyana but also countless others affected by this condition.

How You Can Help

Every donation, no matter how small, brings us one step closer to a cure. Your generous support will directly fund vital research initiatives, including clinical trials, laboratory studies, and innovative treatment approaches. Together, we can make a difference and give hope to families like ours who are battling NMO. All funds provided will be directed to labs/universities and other organisations doing this vital research.

Join Us in the Fight Against NMO

Eliyana's courage and resilience inspire us every day. We invite you to join us in this fight by contributing to our campaign. Your donation will have a lasting impact, helping to create a brighter future for her and others facing NMO. Thank you for your kindness and generosity.